IRCT20230222057495N5招募中Unknown
Bioequivalence study of 300 mg ursodeoxycholic acid capsule of Kimidaro Pharmaceutical Company compared to 300 mg ursodeoxycholic acid of Aurobindo Pharma LTD, India on healthy volunteers
Chemidarou Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy volunteers between the ages of 18 and 50
- •All candidates must be non-smokers
- •Body mass index less than 30 kg per square meter
排除标准
- •Blood pressure less than 90 over 60 mm Hg or more than 140 over 90 mm Hg
- •Consumption of any drugs, alcohol or tobacco products within 2 weeks before receiving the drug
研究者
相似试验
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N16Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N30Tabriz University of Medical Sciences24
招募中
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIRCT20210519051345N25Tabriz University of Medical Sciences24
招募中
Unknown
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N47Tabriz University of Medical Sciences24
尚未招募
不适用
Investigating the in vivo bioequivalence of Ursodeoxycholic acid 300 mg capsuleIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N19Tabriz University of Medical Sciences24